000 01318 a2200397 4500
005 20250517171238.0
264 0 _c20190805
008 201908s 0 0 eng d
022 _a1468-2060
024 7 _a10.1136/annrheumdis-2017-211430
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aOryoji, Kensuke
245 0 0 _aShared epitope positivity is related to efficacy of abatacept in rheumatoid arthritis.
_h[electronic resource]
260 _bAnnals of the rheumatic diseases
_c08 2018
300 _a1234-1236 p.
_bdigital
500 _aPublication Type: Letter
650 0 4 _aAbatacept
_xtherapeutic use
650 0 4 _aAged
650 0 4 _aAntirheumatic Agents
_xtherapeutic use
650 0 4 _aArthritis, Rheumatoid
_xdrug therapy
650 0 4 _aEpitopes
_xgenetics
650 0 4 _aFemale
650 0 4 _aHLA-DRB1 Chains
_xgenetics
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
700 1 _aYoshida, Kenji
700 1 _aKashiwado, Yusuke
700 1 _aTanaka, Keiko
700 1 _aMizuki, Shin-Ichi
700 1 _aTsukamoto, Hiroshi
700 1 _aKamada, Kazuo
700 1 _aAkashi, Koichi
773 0 _tAnnals of the rheumatic diseases
_gvol. 77
_gno. 8
_gp. 1234-1236
856 4 0 _uhttps://doi.org/10.1136/annrheumdis-2017-211430
_zAvailable from publisher's website
999 _c27487934
_d27487934